Health Catalyst (HCAT) Stock Price, News & Analysis $7.40 -0.36 (-4.64%) (As of 11:04 AM ET) Add Compare Share Share Today's Range$7.35▼$7.6650-Day Range$6.71▼$10.1652-Week Range$6.60▼$15.87Volume104,481 shsAverage Volume479,310 shsMarket Capitalization$425.87 millionP/E RatioN/ADividend YieldN/APrice Target$13.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Health Catalyst MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside79.9% Upside$13.40 Price TargetShort InterestHealthy2.99% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.00Based on 3 Articles This WeekInsider TradingSelling Shares$38,879 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.90) to ($0.88) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.37 out of 5 starsMedical Sector283rd out of 942 stocksHealth Information Services Industry3rd out of 7 stocks 3.3 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 5 buy ratings, 5 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.40, Health Catalyst has a forecasted upside of 79.9% from its current price of $7.45.Amount of Analyst CoverageHealth Catalyst has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.99% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently increased by 13.91%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 2.2 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Health Catalyst this week, compared to 2 articles on an average week.Search Interest3 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows3 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $38,879.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions86.63% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.90) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -3.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -3.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Health Catalyst Stock (NASDAQ:HCAT)Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.Read More HCAT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Stock News HeadlinesDecember 11, 2023 | americanbankingnews.comCritical Review: Health Catalyst (NASDAQ:HCAT) and Taboola.com (NASDAQ:TBLA)December 6, 2023 | bizjournals.comPortland health care AI startup names new CEODecember 11, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comDecember 2, 2023 | americanbankingnews.comFinancial Comparison: Health Catalyst (NASDAQ:HCAT) and Taboola.com (NASDAQ:TBLA)November 13, 2023 | msn.comPiper Sandler Upgrades Health Catalyst (HCAT)November 13, 2023 | finance.yahoo.comHealth Catalyst (HCAT) Stock Trades Up, Here Is WhyNovember 7, 2023 | finance.yahoo.comHealth Catalyst, Inc. (NASDAQ:HCAT) Q3 2023 Earnings Call TranscriptNovember 6, 2023 | finance.yahoo.comHealth Catalyst Inc (HCAT) Reports 8% Revenue Growth in Q3 2023December 11, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.November 2, 2023 | finance.yahoo.comCompared to Estimates, Health Catalyst (HCAT) Q3 Earnings: A Look at Key MetricsNovember 2, 2023 | finance.yahoo.comHealth Catalyst Acquires ERS, Bolsters Tech-Enabled Managed Services Offering with Data Abstraction and Oncology Registry Management CapabilitiesNovember 2, 2023 | finance.yahoo.comAccountable Health Partners, A Clinically Integrated Network, Signs Multi-Year Partnership with Health Catalyst to Advance Operational ImprovementsNovember 2, 2023 | finance.yahoo.comHealth Catalyst Reports Third Quarter 2023 ResultsNovember 2, 2023 | axios.comGeneral Catalyst hospital play flips VC script, finds new hurdlesOctober 31, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Generation Bio (GBIO), Health Catalyst (HCAT)October 30, 2023 | axios.comGeneral Catalyst enters a "struggle for the soul" of the US hospitalOctober 27, 2023 | msn.comHealth Catalyst raises FY revenue outlookOctober 27, 2023 | finance.yahoo.comHealth Catalyst Reports Third Quarter 2023 Preliminary ResultsOctober 26, 2023 | axios.comGeneral Catalyst hospital: A risky bet with worthy ambitionsOctober 25, 2023 | finance.yahoo.comHealth Catalyst to Announce Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, November 8, 2023October 22, 2023 | finance.yahoo.comHealth Catalyst Insider Ups Holding By 42% During YearOctober 17, 2023 | finance.yahoo.comAll You Need to Know About Health Catalyst (HCAT) Rating Upgrade to Strong BuyOctober 14, 2023 | msn.comWall Street Breakfast Catalyst Watch: Weight Loss Drugs Make An ImpactOctober 14, 2023 | techcrunch.comDeal Dive: Why does General Catalyst want to buy a healthcare system?September 27, 2023 | finance.yahoo.comHealth Catalyst Pop Analyzer™ and Health Catalyst Care Flow™ Achieve NCQA Population Health Management Prevalidation StatusSeptember 15, 2023 | nasdaq.comCantor Fitzgerald Reiterates Health Catalyst (HCAT) Overweight RecommendationSeptember 5, 2023 | finance.yahoo.comHealth Catalyst Recognized in Five Gartner® Hype Cycle™ ReportsSee More Headlines Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2023Today12/11/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year FoundedN/APrice Target and Rating Average Stock Price Target$13.40 High Stock Price Target$18.00 Low Stock Price Target$8.00 Potential Upside/Downside+72.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($2.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-137,400,000.00 Net Margins-42.62% Pretax Margin-42.53% Return on Equity-14.08% Return on Assets-7.67% Debt Debt-to-Equity Ratio0.60 Current Ratio4.85 Quick Ratio4.85 Sales & Book Value Annual Sales$276.24 million Price / Sales1.62 Cash FlowN/A Price / Cash FlowN/A Book Value$7.76 per share Price / Book1.00Miscellaneous Outstanding Shares57,550,000Free Float55,996,000Market Cap$446.59 million OptionableNot Optionable Beta1.29 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Comp: $158.9kMr. Bryan Truman Hunt (Age 36)Chief Financial Officer Comp: $370.46kMr. Daniel H. Orenstein (Age 53)Senior Advisor Comp: $356.56kMr. Kevin Freeman (Age 50)Chief Commercial Officer Comp: $405.9kMs. Anne Marie Bickmore (Age 60)COO & Chief Product Officer Mr. Jason Alger (Age 39)Chief Accounting Officer Mr. Dave RossChief Technology OfficerMr. Adam BrownSenior Vice President of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGeneral Counsel & Secretary of the BoardMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMore ExecutivesKey CompetitorsAnaptysBioNASDAQ:ANABMarinus PharmaceuticalsNASDAQ:MRNSJanux TherapeuticsNASDAQ:JANXAllogene TherapeuticsNASDAQ:ALLOBicycle TherapeuticsNASDAQ:BCYCView All CompetitorsInsiders & InstitutionsJason AlgerSold 2,177 sharesTotal: $16,436.35 ($7.55/share)American Century Companies Inc.Bought 62,010 shares on 11/30/2023Ownership: 1.143%Deutsche Bank AGSold 172,716 shares on 11/24/2023Ownership: 0.059%Jacobs Levy Equity Management Inc.Sold 271,383 shares on 11/17/2023Ownership: 1.325%Public Employees Retirement System of OhioSold 12,000 shares on 11/16/2023Ownership: 0.146%View All Insider TransactionsView All Institutional Transactions HCAT Stock Analysis - Frequently Asked Questions Should I buy or sell Health Catalyst stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last twelve months. There are currently 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HCAT shares. View HCAT analyst ratings or view top-rated stocks. What is Health Catalyst's stock price target for 2024? 10 brokers have issued 1-year price targets for Health Catalyst's shares. Their HCAT share price targets range from $8.00 to $18.00. On average, they expect the company's share price to reach $13.40 in the next year. This suggests a possible upside of 79.9% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts. How have HCAT shares performed in 2023? Health Catalyst's stock was trading at $10.63 at the beginning of the year. Since then, HCAT shares have decreased by 29.9% and is now trading at $7.45. View the best growth stocks for 2023 here. Are investors shorting Health Catalyst? Health Catalyst saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,720,000 shares, an increase of 13.9% from the October 31st total of 1,510,000 shares. Based on an average trading volume of 466,800 shares, the days-to-cover ratio is presently 3.7 days. View Health Catalyst's Short Interest. When is Health Catalyst's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our HCAT earnings forecast. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings data on Thursday, November, 2nd. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.05. The business had revenue of $73.77 million for the quarter, compared to analysts' expectations of $72.73 million. Health Catalyst had a negative net margin of 42.62% and a negative trailing twelve-month return on equity of 14.08%. What ETFs hold Health Catalyst's stock? ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR FactSet Innovative Technology ETF (XITK) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Health Catalyst issued on next quarter's earnings? Health Catalyst issued an update on its third quarter 2023 earnings guidance on Friday, October, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $73.77 million-$73.77 million, compared to the consensus revenue estimate of $72.66 million. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL). When did Health Catalyst IPO? (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (3.44%), Primecap Management Co. CA (1.95%), Nepsis Inc. (1.59%), Bank of New York Mellon Corp (1.50%), Jacobs Levy Equity Management Inc. (1.33%) and Bares Capital Management Inc. (1.22%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn, Paul Horstmeier and Timothy G Ferris. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:HCAT) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.